These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 22927098)
41. Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease. Boeve BF Lancet Neurol; 2005 Mar; 4(3):137-8. PubMed ID: 15721821 [No Abstract] [Full Text] [Related]
42. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies. Wesnes KA; Aarsland D; Ballard C; Londos E Int J Geriatr Psychiatry; 2015 Jan; 30(1):46-54. PubMed ID: 24737460 [TBL] [Abstract][Full Text] [Related]
43. Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fall. Kudo Y; Imamura T; Sato A; Endo N Dement Geriatr Cogn Disord; 2009; 27(2):139-46. PubMed ID: 19182481 [TBL] [Abstract][Full Text] [Related]
44. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471 [TBL] [Abstract][Full Text] [Related]
46. Treatment of Lewy-body dementias and psychopathology. Marsh L Lancet Neurol; 2010 Oct; 9(10):943-5. PubMed ID: 20729149 [No Abstract] [Full Text] [Related]
47. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Jellinger KA Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163 [No Abstract] [Full Text] [Related]
48. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. Thomas AJ; Burn DJ; Rowan EN; Littlewood E; Newby J; Cousins D; Pakrasi S; Richardson J; Sanders J; McKeith IG Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744 [TBL] [Abstract][Full Text] [Related]
49. Characteristics of eating and swallowing problems in patients who have dementia with Lewy bodies. Shinagawa S; Adachi H; Toyota Y; Mori T; Matsumoto I; Fukuhara R; Ikeda M Int Psychogeriatr; 2009 Jun; 21(3):520-5. PubMed ID: 19257916 [TBL] [Abstract][Full Text] [Related]
50. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences]. Drach LM Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015 [TBL] [Abstract][Full Text] [Related]
51. Definition and diagnosis of dementia with Lewy bodies. Ballard CG Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():15-24. PubMed ID: 14676465 [TBL] [Abstract][Full Text] [Related]
53. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105 [TBL] [Abstract][Full Text] [Related]
54. Visual hallucinations and altered visual information processing in Parkinson disease and dementia with Lewy bodies. Kurita A; Murakami M; Takagi S; Matsushima M; Suzuki M Mov Disord; 2010 Jan; 25(2):167-71. PubMed ID: 20063433 [TBL] [Abstract][Full Text] [Related]
55. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. Aarsland D; Perry R; Larsen JP; McKeith IG; O'Brien JT; Perry EK; Burn D; Ballard CG J Clin Psychiatry; 2005 May; 66(5):633-7. PubMed ID: 15889951 [TBL] [Abstract][Full Text] [Related]
56. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Ikeda M; Mori E; Kosaka K; Iseki E; Hashimoto M; Matsukawa N; Matsuo K; Nakagawa M; Dement Geriatr Cogn Disord; 2013; 36(3-4):229-41. PubMed ID: 23949147 [TBL] [Abstract][Full Text] [Related]